Heterocyclic Compounds in Medicinal Chemistry
Deadline for manuscript submissions: 30 June 2024 | Viewed by 6992
Interests: drug design and synthesis; medicinal chemistry; organic synthesis; antimicrobial agents; structure–activity relationship; antiviral agents; antiparasitic agents; anticancer agents; antiprotozoal agents
Special Issues, Collections and Topics in MDPI journals
Interests: synthesis of heterocycles; medicinal chemistry; organic chemistry; medicinal chemistry and drug design; medicinal chemistry CNS drug discovery and delivery
The development of new medicinal agents is pivotal for the maintenance of a high quality of life as well as a healthy and productive society. Heterocycles play a key role in the biological activity of many small molecule drugs due to their capability of forming hydrogen bond, altering the polarity and modulating lipophilicity at specific sites in the pathogen or host with the overall effect of inhibiting the biological processes that lead to the progression of diseases. Indeed, most of the organic compounds used as therapeutics or intermediates utilized for their synthesis contain heterocyclic motifs that can improve pharmacological, pharmacokinetic, toxicological and physicochemical properties of compounds, making them more effective as therapeutic agents. heterocycles endowed with any biological action. Contributions that highlight the importance of heterocycles that are widely found in: agrochemicals, dyes, cosmetics and functional materials are also welcome. The aim of the present Special Issue is Heterocycle is a ring with at least one atom that is not carbon. Nitrogen, oxygen, and sulfur are the primary elements seen in common heterocycles, which play a critical role in drug discovery. Based on the size of the ring, there are three, four, five, six, seven or more membered rings, as well as fused, bicyclic and macrocyclic heterocycles. Furthermore, they are grouped as aromatic, saturated or unsaturated. Depending on the structure and on the type of bonds, such compounds show different acid-base properties and they can contain one, two or more heteroatoms.
This Special Issue will acknowledge research papers with topics including, but not limited to, the preparation of aromatic and non-aromatic also an overview primarily of the state of the art of synthetic methods and recent advances in the synthesis of heterocycles.
Dr. Valentina Noemi Madia
Dr. Davide Ialongo
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- bioactive compounds
- drug design and discovery
- in silico studies
- anticancer agents
- antifungal agents
- anti-inflammatory agents
- antimicrobial agents
- antiviral agents